With the aggravation of aging in my country and the increase of sub-healthy population, people's health awareness is increasing day by day, and investment in the medical field is also increasing.

Rapid Development of In Vitro Diagnostic Reagents

The in vitro diagnosis industry has been in a period of rapid growth, and in vitro diagnosis involves many fields: downstream medical institutions, upstream testing equipment, testing reagents, etc., of course, there are third-party diagnostic institutions. There are many types of in vitro diagnostic reagents, and chemiluminescence reagents are a lucrative and promising segment.

According to the analysis of the Prospective Industry Research Institute, the market size of my country's in vitro diagnostic industry is expected to reach 60 billion yuan this year, and the proportion of immunodiagnosis is also increasing, and it is expected to reach 40% this year. And immunodiagnosis requires the use of chemiluminescence reagents. As an advanced technology for immunodiagnosis, its market cultivation period has passed, and it will enter a period of rapid growth in the future, with an average annual growth rate of 30%.

Therefore, it can be said that chemiluminescence reagents are a good investment direction in the field of immunodiagnosis and in vitro diagnosis. Moreover, from the demand side, the incremental demand alone has now reached 20 billion yuan. In downstream medical institutions, the coverage of chemiluminescence detection is extremely wide, involving almost all projects of large medical institutions and independent diagnostic medical institutions; especially now that regional testing centers and graded diagnosis and treatment are in full swing, which will also promote the chemiluminescence reagent industry. development of.

But unfortunately, most of the chemiluminescent preparations used by medical institutions in my country are imported from abroad, and the import ratio is even as high as 90%. However, import substitution is also a trend. At present, my country's self-developed chemiluminescent preparations have been initially recognized by the market, and with the continuous breakthrough of technology, my country is fully hopeful to achieve all domestic production in the future.

From the attitude of downstream medical institutions, especially large hospitals, towards chemiluminescent preparations, it can be seen that this type of product is the "cost item" of medical institutions. The inspection quality of domestic products is gradually approaching that of imported products, so there is no doubt that hospitals must It is to choose domestic products with higher cost performance. Secondly, from the perspective of research and development capabilities, my country's chemiluminescent preparation manufacturers have gradually mastered the core technology, and the types of reagents are also rapidly enriched, but the stability and accuracy of the reagents need to be further improved.

Furthermore, if manufacturers of chemiluminescence reagents can build sound marketing channels and establish a brand image in tertiary hospitals, it is not impossible for them to impact secondary hospitals in the future; The market will be captured by manufacturers.

Therefore, manufacturers need to vigorously develop downstream channels, improve their own product lines, or cooperate with testing equipment manufacturers to provide overall solutions for downstream medical institutions, so in the future development process, it is not an extravagant hope to conquer the city.